Quick Answer
PLIANT THERAPEUTICS, INC. reported Stockholders Equity of $181.21 million for fiscal year 2025.
PLIANT THERAPEUTICS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $181.21M | -40.4% |
| 2024 | $304.08M | -35.8% |
| 2023 | $473.58M | +51.1% |
| 2022 | $313.34M | +57.4% |
| 2021 | $199.06M | -29.7% |
| 2020 | $283.06M | +471.0% |
| 2019 | -$76.30M | -6.8% |
| 2018 | -$71.47M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $200.31M | -42.1% | -9.0% |
| June 30, 2025 | $220.08M | -44.0% | -14.4% |
| March 31, 2025 | $257.16M | -41.2% | -15.4% |
| December 31, 2024 | $304.08M | -35.8% | -12.1% |
| September 30, 2024 | $345.82M | -31.3% | -11.9% |
| June 30, 2024 | $392.68M | -26.3% | -10.2% |
| March 31, 2024 | $437.33M | -22.2% | -7.7% |
| December 31, 2023 | $473.58M | +51.1% | -5.9% |
- PLIANT THERAPEUTICS, INC. showed a decrease of -40.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, PLIANT THERAPEUTICS, INC.’s stockholders equity has grown by 353.5% (from -$71.47 million to $181.21 million).
- The most recent figure is from PLIANT THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: